A Form 4 filed with the SEC on September 16, 2026 discloses that Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), sold 4,000 ordinary shares on September 14, 2026 under a Rule 10b5-1 trading plan.
Eric M. Specter, Chief Accounting Officer of Five Below, Inc., reported a sale of 5,500 shares of common stock on September 14, 2026, in a filing submitted to the SEC on September 16, 2026.
Joseph Miller, Vice President and Controller of Consolidated Edison, Inc. (NYSE:ED), filed a Form 4 on September 16, 2026, disclosing a purchase of common stock on September 15, 2026, along with updated beneficial ownership figures.
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), filed a Form 4 on September 16, 2026, disclosing the sale of 5,000 ordinary shares on September 14, 2026.
Insulet Corporation filed a Form 8-K with the SEC on September 16, 2026, disclosing that its Talent and Compensation Committee approved a new Nonqualified Deferred Compensation Plan on September 14, 2026, effective January 1, 2027.
Great Southern Bancorp, Inc. filed a Form 8-K on September 16, 2026, reporting the declaration of a $0.43 per common share dividend for the third quarter of the calendar year ending December 31, 2026.
AH Realty Trust, Inc. filed a Form 8-K on September 16, 2026, disclosing under Regulation FD that its President and CEO and its CFO and Treasurer will use investor presentation materials in meetings with investors beginning that same date.
Mission Produce, Inc. filed a Form 8-K with the SEC on September 16, 2026, disclosing facility closures and workforce reductions tied to the integration of Calavo Growers, Inc. following the completion of that acquisition on May 28, 2026.
Replimune Group, Inc. filed a Form 8-K on September 16, 2026, reporting that stockholders at the company's September 15, 2026 annual meeting approved an amendment to its certificate of incorporation doubling authorized common shares and ratifying its independent auditor, among other matters.
Halliburton Company filed a Form 8-K on September 16, 2026, disclosing that its independent directors elected Mr. Maurice S. Smith as Lead Independent Director, effective September 15, 2026.